This study assessed the safety and patient satisfaction with conversion from sildenafil to tadalafil. Methods In this multicenter, prospective, 6-month study, patients with PAH were instructed to take their last dose of sildenafil in the evening and initiate tadalafil 40 mg/d the next morning. Patients completed the Treatment Satisfaction
Price: Tadalafil Sildenafil ($6.00/dose) Tadalafil Daily Mint ($1.3/dose) Tadalafil Daily pill ($1.07/dose) Sildenafil pill ($4/dose) Tadalafil pill ($4.5/dose) Tadalafil Sildenafil ($12/dose)
Conversion to tadalafil resulted in significant improvement in patient ratings of therapy convenience. Conclusions: Transition of patients from sildenafil to tadalafil was usually well tolerated, with improved convenience and may enhance treatment satisfaction. Keywords sildenafil, tadalafil, switch, pulmonary arterial hypertension, patient
DOI: 10.1177/ Corpus ID: ; Conversion From Sildenafil to Tadalafil @article{Frantz2025ConversionFS, title={Conversion From Sildenafil to Tadalafil}, author={Robert P. Frantz and Louise A. Durst and Charles D. Burger and Ronald Oudiz and Robert C. Bourge and Veronica Franco and Aaron B. Waxman and Susanne McDevitt and Susan A Walker}
Conversion From Sildenafil To Tadalafil: Initial Results From The Sildenafil To Tadalafil In Pulmonary Arterial Hypertension (SITAR) Study Abstract Send to Citation Mgr. Add to
Conversion From Sildenafil to Tadalafil: Results From the Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) Study A greater percentage of patients were satisfied than were dissatisfied after conversion to tadalafil (55% vs 19% at 90 days), while 26% felt about the same degree of satisfaction.
This study assessed the safety and patient satisfaction with conversion from sildenafil to tadalafil. METHODS: In this multicenter, prospective, 6-month study, patients with PAH were instructed to take their last dose of sildenafil in the evening and initiate tadalafil 40 mg/d the next morning. Patients completed the Treatment Satisfaction
Conversion From Sildenafil To Tadalafil: Initial Results From The Sildenafil To Tadalafil In Pulmonary Arterial Hypertension (SITAR) Study Robert P. Frantz . x. Robert P. Frantz. Search
This study assessed the safety and patient satisfaction with conversion from sildenafil to tadalafil. Methods: In this multicenter, prospective, 6-month study, patients with PAH were instructed to take their last dose of sildenafil in the evening and initiate tadalafil 40 mg/d the next morning. Patients completed the Treatment Satisfaction
Comments